Coronavirus

US halts J&J one-shot COVID-19 vaccinations over “extremely rare” clot risk

US halts J&J one-shot COVID-19 vaccinations over “extremely rare” clot risk

US immunizations with the Johnson & Johnson COVID-19 vaccine have been put on hold, as the CDC and FDA assesses six reported cases of rare blood clotting in America. The J&J Jannsen vaccine has been administered more than 6.8 million times in the US so far, since the one-shot drug received authorization under the FDA's pandemic EUA program.

Continue Reading

CDC’s latest COVID-19 update: Vaccines and variants take center stage

CDC’s latest COVID-19 update: Vaccines and variants take center stage

The CDC published its COVID-19 weekly review on Friday, revealing that as of the end of the week, more than 174 million vaccine doses have been administered in the US, including more than 66 million people who are now fully vaccinated. As well, the agency discusses the SARS-CoV-2 variants circulating in the US and explains why it is important to 'remain vigilant.'

Continue Reading

Researchers find link between antipsychotics and COVID-19 protection

Researchers find link between antipsychotics and COVID-19 protection

Antipsychotics, a type of medication that is usually prescribed to treat psychotic disorders, may have a protective effect against COVID-19. That's according to a new study from the University of Seville, which reports that people who take antipsychotics were less likely to contract the virus and that among those who did, the odds of reaching a severe life-threatening state were lower.

Continue Reading

Pfizer-BioNTech ask FDA to expand COVID-19 vaccine to 12-15 year olds

Pfizer-BioNTech ask FDA to expand COVID-19 vaccine to 12-15 year olds

Pfizer and BioNTech are requesting FDA authorization to expand their COVID-19 vaccine to children as young as 12, claiming recently-released trial results demonstrate the immunizations' safety. Currently, the Pfizer-BioNTech vaccine, BNT162b2, is being administered in the US under an FDA emergency use authorization (EUA) for people aged 16 or above.

Continue Reading

J&J’s one-shot COVID-19 vaccine is under blood clot investigation

J&J’s one-shot COVID-19 vaccine is under blood clot investigation

Johnson & Johnson's single-shot COVID-19 vaccine is being investigated by the European Medicines Agency over blood clot concerns, the second coronavirus vaccine to fall under the microscope for potentially fatal side-effects. The EMA's safety committee, PRAC, recommended continued use of the University fo Oxford and AstraZeneca's vaccine earlier this week, though required possible blood issues be added to the list of rare risks.

Continue Reading

COVID-19 biosensors could make your phone a virus-spotter

COVID-19 biosensors could make your phone a virus-spotter

GE is working on tiny sensors that could spot the COVID-19 virus, small enough to integrate into smartphones, wearables, and other surfaces as a digital watchdog for potential routes of infection. The electronic nano-sensors distill down what would traditionally demand large and complex lab equipment into something far smaller, focused on detecting a specific thing such as coronavirus.

Continue Reading

CDC tells Americans to avoid travel to Canada even if fully vaccinated

CDC tells Americans to avoid travel to Canada even if fully vaccinated

A significant portion of the US has been fully vaccinated against COVID-19 and many more will be added to the numbers in the next few weeks. This, naturally, raises questions about travel and what a vaccinated person can safely do following the vaccination waiting period. According to the CDC, a trip to Canada shouldn't be on your list -- even if you're fully vaccinated.

Continue Reading

EU regulator finds “very rare” AstraZeneca vaccine blood clot risk: The symptoms to watch for

EU regulator finds “very rare” AstraZeneca vaccine blood clot risk: The symptoms to watch for

The AstraZeneca COVID-19 vaccine could lead to blood clots in a small subset of people, the European drug regulator has concluded, though it's a "very rare" possibility and shouldn't prevent immunizations in general. The European Medicines Agency (EMA) had been assessing the safety of Vaxzevria - developed by the University of Oxford in the UK and AstraZeneca - after reports of an uptick in dangerous blood clots among some people who had been given the drug.

Continue Reading

Biden moves ‘open season’ COVID-19 vaccine date to April 19

Biden moves ‘open season’ COVID-19 vaccine date to April 19

President Biden has announced that the 'open season' deadline for states to make everyone eligible to get the COVID-19 vaccine has been moved back to April 19. This is the latest adjustment to the vaccination timeline, reducing the wait for the general public from the original May 1 deadline. The updated deadline joins the revised goal to reach 200 million administered shots by Biden's 100th day in office.

Continue Reading

There’s a big ketchup shortage, but that doesn’t mean what you think

There’s a big ketchup shortage, but that doesn’t mean what you think

Ketchup, the wonderfully acidic condiment for your favorite potato snacks, is currently in short supply -- and, yes, you can blame the pandemic for this latest supply issue. However, if you're already thinking about stocking up in hopes of enjoying your previously stockpiled potatoes throughout the rest of the year, think again. The shortage isn't quite what you anticipate.

Continue Reading

Researchers warn US is fueling Canada’s growing COVID-19 conspiracies

Researchers warn US is fueling Canada’s growing COVID-19 conspiracies

A new study from McGill University has found that misinformation about the COVID-19 vaccine originating from the United States may be fueling conspiracy theories and other issues in Canada. Social media appears to be a driving factor in this cross-border information exchange, with Canadians who report frequent Twitter use experiencing high exposure to American news sources.

Continue Reading

Challenge.gov launches mask innovation challenge with $500,000 in cash prizes

Challenge.gov launches mask innovation challenge with $500,000 in cash prizes

Thanks to the coronavirus pandemic, we are all familiar with facemasks, sometimes called barrier face coverings. Masks of this order worn on the face to protect the wearer and help filter respiratory secretions from the wearer to prevent disease transmission. All around the world, public health organizations encourage citizens to wear masks in public spaces to reduce the spread of respiratory diseases such as COVID-19.

Continue Reading

1 2 3 4 Next